Publisher： Bentham Science Publishers
E-ISSN： 1873-5576|4|5|385-402
ISSN： 1568-0096
Source： Current Cancer Drug Targets, Vol.4, Iss.5, 2004-08, pp. : 385-402
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
p53 as a target for improved cancer therapy
By Wiman K.G.
Expert Opinion on Therapeutic Targets, Vol. 3, Iss. 2, 1999-06 ,pp. :
Access to resources
Recommend
p53 as a drug target in cancer therapy
Expert Opinion on Therapeutic Patents, Vol. 11, Iss. 6, 2001-06 ,pp. :
Pharmacological Activation of p53 in Cancer Cells
Current Pharmaceutical Design, Vol. 17, Iss. 6, 2011-02 ,pp. :
P53 and Beta-Catenin in Colorectal Cancer Progression
Current Pharmaceutical Design, Vol. 9, Iss. 24, 2003-09 ,pp. :
P53 Family: At the Crossroads in Cancer Therapy
Current Medicinal Chemistry, Vol. 16, Iss. 32, 2009-11 ,pp. :